BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27160868)

  • 1. Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.
    Lin X; Hu Q; Zhang R; Hu Y; Xu X; Lv H
    J Hosp Infect; 2016 Sep; 94(1):65-7. PubMed ID: 27160868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
    Cai JC; Zhou HW; Zhang R; Chen GX
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.
    Queenan AM; Shang W; Schreckenberger P; Lolans K; Bush K; Quinn J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3485-7. PubMed ID: 17005839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital.
    Silva KE; Cayô R; Carvalhaes CG; Patussi Correia Sacchi F; Rodrigues-Costa F; Ramos da Silva AC; Croda J; Gales AC; Simionatto S
    J Clin Microbiol; 2015 Jul; 53(7):2324-8. PubMed ID: 25878341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC Programme.
    Gales AC; Biedenbach DJ; Winokur P; Hacek DM; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2001 Feb; 39(2):125-7. PubMed ID: 11248526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
    Gomez E; Urban C; Mariano N; Colon-Urban R; Eng RH; Huang DB; Chiang T
    Microb Drug Resist; 2011 Jun; 17(2):251-7. PubMed ID: 21332362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serratia marcescens harbouring SME-type class A carbapenemases in Canada and the presence of blaSME on a novel genomic island, SmarGI1-1.
    Mataseje LF; Boyd DA; Delport J; Hoang L; Imperial M; Lefebvre B; Kuhn M; Van Caeseele P; Willey BM; Mulvey MR
    J Antimicrob Chemother; 2014 Jul; 69(7):1825-9. PubMed ID: 24659751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China.
    Zhang R; Zhou HW; Cai JC; Chen GX
    J Antimicrob Chemother; 2007 Mar; 59(3):574-6. PubMed ID: 17251347
    [No Abstract]   [Full Text] [Related]  

  • 9. High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt.
    Khalifa HO; Soliman AM; Ahmed AM; Shimamoto T; Hara T; Ikeda M; Kuroo Y; Kayama S; Sugai M; Shimamoto T
    Microb Drug Resist; 2017 Oct; 23(7):838-844. PubMed ID: 28191865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic characterization of two carbapenem-resistant
    Jia J; Huang L; Zhang L; Sheng Y; Chu W; Xu H; Xu A
    Front Cell Infect Microbiol; 2023; 13():1075255. PubMed ID: 36844412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): a 4-year experience in Taiwan.
    Yu WL; Ko WC; Cheng KC; Chen HE; Lee CC; Chuang YC
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):460-7. PubMed ID: 18455901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo acquisition of a plasmid-mediated bla(KPC-2) gene among clonal isolates of Serratia marcescens.
    Tsakris A; Voulgari E; Poulou A; Kimouli M; Pournaras S; Ranellou K; Kosmopoulou O; Petropoulou D
    J Clin Microbiol; 2010 Jul; 48(7):2546-9. PubMed ID: 20463153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens.
    Biagi M; Shajee A; Vialichka A; Jurkovic M; Tan X; Wenzler E
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and molecular characterization of extended-spectrum beta-lactamase-producing Enterobacter spp., Pantoea agglomerans, and Serratia marcescens isolates from a Bulgarian hospital.
    Markovska RD; Stoeva TJ; Bojkova KD; Mitov IG
    Microb Drug Resist; 2014 Apr; 20(2):131-7. PubMed ID: 24171449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
    Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
    Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
    Yigit H; Queenan AM; Anderson GJ; Domenech-Sanchez A; Biddle JW; Steward CD; Alberti S; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1151-61. PubMed ID: 11257029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
    Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and biochemical characterization of GES-16, a new GES-type β-lactamase with carbapenemase activity in Serratia marcescens.
    Streling AP; Barbosa PP; Marcondes MF; Nicoletti AG; Picão RC; Pinto EC; Marques EA; Oliveira V; Gales AC
    Diagn Microbiol Infect Dis; 2018 Oct; 92(2):147-151. PubMed ID: 29861147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Crivaro V; Bagattini M; Salza MF; Raimondi F; Rossano F; Triassi M; Zarrilli R
    J Hosp Infect; 2007 Oct; 67(2):135-41. PubMed ID: 17884248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KPC-PRODUCING Serratia marcescens IN A HOME-CARE PATIENT FROM RECIFE, BRAZIL.
    Margate E; Magalhães V; Fehlberg LC; Gales AC; Lopes AC
    Rev Inst Med Trop Sao Paulo; 2015; 57(4):359-60. PubMed ID: 26422164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.